Data for: SERUM AMYLOID A AS AN INDICATOR OF IMPENDING XENOGRAFT FAILURE OTHER - XENOTRANSPLANTATION
收藏官方服务：
资源简介：
Please see attachments
应用场景：
创建时间：
2020-03-31
相关数据集
The prediction value of platelet-derived growth factor for major adverse cardiovascular events in patients with acute non-ST-segment elevation myocardial infarction
The value of plasma Platelet-Derived Growth Factor (PDGF) as a biomarker in predicting major adverse cardiovascular events (MACEs) in patients with acute non-ST-segment elevation myocardial infarction
DataCite Commons2024-02-14 更新60
Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer
This study evaluates the relationship of biomarker expression and efficacy of bevacizumab plus chemotherapy in patients with unresectable/metastatic colorectal cancer. Before the treatment, the invest
NIAID Data Ecosystem60
Data_Sheet_1_Towards biomarker-based optimization of deep brain stimulation in Parkinson’s disease patients.pdf
BackgroundSubthalamic deep brain stimulation (DBS) is an established therapy to treat Parkinson’s disease (PD). To maximize therapeutic outcome, optimal DBS settings must be carefully selected for eac
NIAID Data Ecosystem30
Multiplex predictors of imminent RA diagnosis.
Multiplex predictors of imminent RA diagnosis.
NIAID Data Ecosystem60
Data_Sheet_1_Higher serum tissue inhibitor of metalloproteinase-1 predicts atrial fibrillation recurrence after radiofrequency catheter ablation.docx
BackgroundTissue inhibitor of metalloproteinase-1 (TIMP-1) levels is strongly associated with cardiac extracellular matrix accumulation and atrial fibrosis. Whether serum levels of TIMP-1 are associat
NIAID Data Ecosystem40
